Heart Disease News and Research

Latest Heart Disease News and Research

Health Net expands Improving the Patient Experience toolkit

Health Net, Inc. has expanded its Improving the Patient Experience toolkit for its contracted providers in three new markets. Piloted first in California in 2010, the insurer now offers the toolkit in Arizona, Oregon and Washington.

8 Nov 2011

CardioNet third quarter revenue decreases 3.2% to $26.6 million

CardioNet, Inc., a leading wireless medical technology company with a current focus on the diagnosis and monitoring of cardiac arrhythmias, today reported results for the third quarter ended September 30, 2011.

8 Nov 2011

First Edition: November 8, 2011

Today's early morning highlights from the major news organizations, including stories on malpractice reforms and previews of voting in Ohio on two ballot questions affecting health care issues and a Mississippi abortion issue.

8 Nov 2011

Wales may adopt new organ donation laws

New legislation in Wales proposes the modification of current organ donation rules. It could mean that relatives would not be able to prevent a dead person's organs being used in transplants if they had not opted out before they died. If the proposals are passed then Wales will be the first in the UK to go forward with the system.

8 Nov 2011

AMERIMED Hospitals now part of Global Health Voyager network

Global Health Voyager, Inc., a publicly-traded, full-service, international medical tourism company, today announced that AMERIMED Hospitals -- spanning key tourist destinations in Mexico including Cabo San Lucas, Cancún, Puerto Vallarta, and San José del Cabo - are now part of the Global Health Voyager network.

8 Nov 2011

Five-year results from Abbott's HUMIRA ATLAS study on ankylosing spondylitis

Abbott today announced five-year results from the open-label extension of the ATLAS study, which evaluated the long-term impact of treatment with HUMIRA (adalimumab) on disease activity, including spinal mobility in patients with active ankylosing spondylitis.

8 Nov 2011

UM launches campaign on medication adherence in Baltimore

Months before U.S. Surgeon General Regina Benjamin, MD, MBA, came to Baltimore on Nov. 2 to officially launch the city's leg of a three-year national campaign to raise awareness about medication adherence, pharmacy students had already taken up the challenge, said Cherokee Layson-Wolf, PharmD, CGP, associate professor of pharmacy practice and science at the University of Maryland School of Pharmacy.

8 Nov 2011

Brain bypass still plays a critical role in management of selected neurovascular disorders

A microsurgical procedure that has lost some ground to advances in endovascular therapy still plays a critical role in the management of selected neurovascular disorders, according to a University Hospitals Case Medical Center neurosurgeon who performs the procedure.

8 Nov 2011

A person's stroke risk profile may help identify future cognitive problems

A new study shows a person's stroke risk profile, which includes high blood pressure, smoking, and diabetes, may also be helpful in predicting whether a person will develop memory and thinking problems later in the life.

8 Nov 2011

FIGMD CEO presents 'Healthcare in India' at ACC Professional and Corporate Consortium meeting

Sanket Baralay President and CEO of FIGMD presented "Healthcare in India" at the ACC Professional and Corporate Consortium meeting October 25th at the ACC Heart House in Washington D.C.

8 Nov 2011

Bristol-Myers Squibb receives FDA approval for Erbitux to treat head and neck cancer

The U.S. Food and Drug Administration today approved Erbitux (cetuximab) for use with chemotherapy to treat patients with late-stage (metastatic) head and neck cancer.

8 Nov 2011

Research: Nucleolar disruption could destroy cancer cells

DAMAGING a cell's nucleolus could destroy cancer cells by increasing levels of the most important tumour prevention protein, p53, reveals research presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool, today.

7 Nov 2011

DSM and Svelte Medical Systems enter into license and supply agreement

DSM, and Svelte® Medical Systems, Inc., a privately held company developing next generation endovascular therapies, today announced they have entered into a license and supply agreement granting Svelte the right to use DSM’s proprietary bioerodible amino acid based drug carrier in the design of their All In One non-thrombogenic, non-inflammatory drug-eluting stent system.

7 Nov 2011

Gilead, CRF commence ranolazine Phase 3 clinical trial for chronic stable angina in post-PCI setting

Gilead Sciences, Inc. and the Cardiovascular Research Foundation (CRF) today announced the initiation of RIVER-PCI (Ranolazine for Incomplete VEssel Revascularization post-PCI), a Phase 3 clinical trial evaluating the utility of ranolazine to prevent major adverse cardiovascular events (MACE) in patients with a history of chronic angina who have incomplete revascularization following percutaneous coronary intervention (PCI).

7 Nov 2011

Groups sound off on exchanges as governors wrestle with HHS over control

The issue of shaping health insurance exchanges is raising controversy even as states worry they'll bear the brunt of the public's anger over the law.

7 Nov 2011

Medtronic CoreValve System for direct aortic and subclavian implantation receives CE Mark

Medtronic, Inc. today announced it has received CE Mark for the Medtronic CoreValve System to be delivered using direct aortic access.

From Medtronic 7 Nov 2011

Mediterranean Diet beneficial even without weight loss

The benefits of the Mediterranean Diet go beyond weight loss, even when weight loss isn't achieved. Researchers from St. Vincent's Hospital, Melbourne, studied 12 patients without diabetes who had nonalcoholic fatty liver disease (NAFLD), and the results of their study demonstrated that liver health was improved even without weight loss.

7 Nov 2011

NewCardio's automated cardiac safety solution selected by top pharma company for Phase I drug study

NewCardio, Inc., a cardiovascular diagnostic solutions developer, announced today that a top 5 global pharmaceutical company has selected QTinno, their automated cardiac safety solution, for an upcoming Phase I drug safety study.

7 Nov 2011

Transgenomic and A. Menarini Diagnostics enter distribution agreement for mutation detection systems

Transgenomic, Inc. and A. Menarini Diagnostics today announced an exclusive distribution agreement for Transgenomic's SURVEYOR Scan and WAVE MCE (Micro-Capillary Electrophoresis) Mutation Detection system to its network of over 2,000 pathologists throughout Europe.

7 Nov 2011